Rejoni Announces First Commercial Case Using the Juveena® Hydrogel System at CCRM Fertility of New Jersey

[#item_full_content]BURLINGTON, Mass.–(BUSINESS WIRE)–Rejoni, Inc., a commercial-stage women’s health company focused on uterine health, today announced that the first commercial procedure using the Juveena Hydrogel System has been performed by Serena H. Chen, MD, Founding Partner and Director of Advocacy, at CCRM Fertility of New Jersey in Livingston, N.J. Intrauterine adhesions (IUAs), the hallmark of Asherman’s syndrome, form when the uterine lining is injured, most often after hysteroscopic surgery or uterin

Leave a Reply

Your email address will not be published. Required fields are marked *